doi: 10.1007/s00394-019-01931-8 149 MohrAEBasileAJMelisaSCSweazeaKLCarpenterKC
Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstrm SZ, Davies MJ, Hovingh GK, Kitzman DW, Mller DV, Verma S, Einfeldt MN, Lindegaard ML, Rasmussen S, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H et al (2024) Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
The reduction in BW from baseline was 22% at the maximum dose tested (mean SEM, 100 nmol/kg from 43.6 1.6 g to 34.8 1.4 g) and 10% from baseline at the lowest dose tested (mean SEM, 1 nmol/kg, from 42.5 1.3 g to 38.2 1.3 g) (Figure 1, A and B)
These products are not interchangeable and should not be used outside of their approved indications
The importance of medical supervision when using Ozempic for weight loss Using Ozempic for weight loss without a doctor's supervision can be very dangerous